Ascend Eyes New Damages After Collapse Of MedMen Buy
Cannabis giant Ascend has more to accuse rival and former business partner MedMen of after their $88 million deal went south and has asked a New York state court for leave...To view the full article, register now.
Already a subscriber? Click here to view full article